Skip to main content
. 2021 Nov;40(11):1433–1442. doi: 10.1016/j.healun.2021.05.010

Table 2.

Patient Clinical Characteristics and Demographic Data

Patient demographics
ABO-C ABO-PE ABO-IA p
Sex
 Male 146 (48.5) 9 (33.3) 3 (30) 0.18
 Female 155 (51.5) 18 (66.7) 7 (70) 0.18
Ethnicity
 White 221 (73.4) 20 (74.1) 5 (50) 0.26
 BAME 75 (24.9) 7 (25.9) 4 (40) 0.56
 Unrecorded/Refused 5 (1.7) 0 1 (10) 0.11
Age at Transplant (years) 10.7 [4.7-14.1] 0.7 [0.5-1.3] 4.1 [3.6-5.4] <0.001
Weight at Transplantation (kg) 26.8 [14.2-44] 7.5 [5.6-10] 13.4 [11-16.4] <0.001
Pre-transplant location data 301 (100) 27 (100) 10 (100)
 Hospital ward/HDU 176 (58.5) 16 (59.3) 4 (40) 0.5
 ICU 77 (25.6) 6 (22.2) 5 (50) 0.2
 Home 48 (15.9) 5 (18.5) 1 (10) 0.82
Pre-transplant mechanical support
 None 211 (70) 17 (63) 4 (40) 0.1
 VAD (LVAD/BiVAD) 81 (27) 9 (33.3) 6 (60) 0.06
 ECMO 35 (11.6)a 2 (7.4)b 3 (30)c 0.16

Abbreviations: ABO-C, Compatible Heart Transplant; ABO-PE, Incompatible Heart Transplantation with Plasma Exchange; ABO-IA, Incompatible Heart Transplantation with Immunoadsorption; BAME, Black, Asian and Minority Ethnicity; HDU, High Dependency Unit; ICU, Intensive CareUnit; VAD, Ventricular Assistance Device; LVAD, Left Ventricular Assistance Device; BiVAD, Biventricular Assistance Device; ECMO, Extracorporeal Membrane Oxygenation.

Continuous variables are presented as median [interquartile range] whilst categorical data are presented as count (percentage).

a

26 patients were converted to LVAD/BiVAD.

b

1 patient was converted to LVAD/BiVAD.

c

two patients were converted to LVAD/BiVAD.